Tech Company Financing Transactions

Relmada Therapeutics Funding Round

Private investors invested in a $180 thousand funding round for Relmada Therapeutics. The financing round was announced on 6/7/2013.

Transaction Overview

Announced On
6/7/2013
Transaction Type
Debt
Amount
$180,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
880 3rd Ave. 12th Floor
New York, NY 10022
USA
Email Address
Overview
Relmada is a clinical stage pain management company with a diversified portfolio of products for the treatment of chronic pain.
Profile
Relmada Therapeutics LinkedIn Company Profile
Social Media
Relmada Therapeutics Company Twitter Account
Company News
Relmada Therapeutics News
Facebook
Relmada Therapeutics on Facebook
YouTube
Relmada Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sergio Traversa
  Sergio Traversa LinkedIn Profile  Sergio Traversa Twitter Account  Sergio Traversa News  Sergio Traversa on Facebook
Chief Medical Officer
Ottavio Vitolo
  Ottavio Vitolo LinkedIn Profile  Ottavio Vitolo Twitter Account  Ottavio Vitolo News  Ottavio Vitolo on Facebook
VP - Operations
Gina DiGuglielmo
  Gina DiGuglielmo LinkedIn Profile  Gina DiGuglielmo Twitter Account  Gina DiGuglielmo News  Gina DiGuglielmo on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/7/2013: JiWire venture capital transaction
Next: 6/7/2013: ChowNow venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary